LOTUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0033 USD | -15.38% |
|
-15.38% | -23.26% |
| 2023 | Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries | MT |
| 2021 | Thai oil firm PTT expands pharma business with $475 million Alvogen deal | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 9.72M | - | - | - | - | - | |
| 44.76B | ||||||
| 23.16B | ||||||
| 16.02B | ||||||
| 14.32B | ||||||
| 13.7B |
